Here’s why there’s a shortage of EpiPens

Dan Gorenstein Aug 23, 2018
Share Now on:
HTML EMBED:
COPY

Here’s why there’s a shortage of EpiPens

Dan Gorenstein Aug 23, 2018
Share Now on:
HTML EMBED:
COPY

The Food and Drug Administration is trying to help mitigate the shortage of EpiPens, those auto-injecting devices used to treat allergic reactions to things like peanuts and bee stings. It’s extended by four months the expiration date for some EpiPen products. The FDA got data from EpiPen maker Mylan that convinced them some of the devices already on the market will work a bit longer.

Click the audio player above to hear the full story. 

As a nonprofit news organization, our future depends on listeners like you who believe in the power of public service journalism.

Your investment in Marketplace helps us remain paywall-free and ensures everyone has access to trustworthy, unbiased news and information, regardless of their ability to pay.

Donate today — in any amount — to become a Marketplace Investor. Now more than ever, your commitment makes a difference.